Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice.
dc.contributor.author | Souza, Ana Carolina Moreira | |
dc.contributor.author | Mosqueira, Vanessa Carla Furtado | |
dc.contributor.author | Silveira, Ana Paula Amariz | |
dc.contributor.author | Antunes, Lidiane Rodrigues | |
dc.contributor.author | Richard, Sylvain | |
dc.contributor.author | Guimarães, Homero Nogueira | |
dc.contributor.author | Guimarães, Andrea Grabe | |
dc.date.accessioned | 2019-04-15T14:15:53Z | |
dc.date.available | 2019-04-15T14:15:53Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Artemether (ATM) cardiotoxicity, its short half-life and low oral bioavailability are the major limiting factors for its use to treat malaria. The purposes of this work were to study free-ATM and ATM-loaded poly-ε-caprolactone nanocapules (ATM-NC) cardiotoxicity and oral efficacy on Plasmodium berghei-infected mice. ATM-NC was obtained by interfacial polymer deposition and ATM was associated with polymeric NC oily core. For cardiotoxicity evaluation, male black C57BL6 uninfected or P. berghei-infected mice received, by oral route twice daily/4 days, vehicle (sorbitol/carboxymethylcellulose), blank-NC, free-ATM or ATMNC at doses 40, 80 or 120 mg kg−1 . Electrocardiogram (ECG) lead II signal was obtained before and after treatment. For ATM efficacy evaluation, female P. berghei-infected mice were treated the same way. ATM-NC improved antimalarial in vivo efficacy and reduced mice mortality. Free-ATM induced significantly QT and QTc intervals prolongation. ATMNC (120 mg kg−1 ) given to uninfected mice reduced QT and QTc intervals prolongation 34 and 30%, respectively, compared with free-ATM. ATM-NC given to infected mice also reduced QT and QTc intervals prolongation, 28 and 27%, respectively. For the first time, the study showed a nanocarrier reducing cardiotoxicity of ATM given by oral route and it was more effective against P. berghei than free-ATM as monotherapy. | pt_BR |
dc.identifier.citation | SOUZA, A. C. M. et al. Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice. Parasitology, v. 145, n. 8, p. 1075-1083, jul. 2018. Disponível em: <https://www.cambridge.org/core/journals/parasitology/article/reduced-cardiotoxicity-and-increased-oral-efficacy-of-artemether-polymeric-nanocapsules-in-plasmodium-bergheiinfected-mice/6932F5098D21304208C64C96DF709932>. Acesso em: 25 fev. 2019. | pt_BR |
dc.identifier.issn | 14698161 | |
dc.identifier.uri | http://www.repositorio.ufop.br/handle/123456789/11013 | |
dc.identifier.uri2 | https://www.cambridge.org/core/journals/parasitology/article/reduced-cardiotoxicity-and-increased-oral-efficacy-of-artemether-polymeric-nanocapsules-in-plasmodium-bergheiinfected-mice/6932F5098D21304208C64C96DF709932 | pt_BR |
dc.language.iso | en_US | pt_BR |
dc.rights | restrito | pt_BR |
dc.subject | Electrocardiogram | pt_BR |
dc.subject | Malaria | pt_BR |
dc.subject | QT interval | pt_BR |
dc.title | Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice. | pt_BR |
dc.type | Artigo publicado em periodico | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- ARTIGO_ReducedCardiotoxicitiIncreased.pdf
- Tamanho:
- 1011.44 KB
- Formato:
- Adobe Portable Document Format
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 924 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição: